Menu

An Editorial Mission: CRISPR Targets Animal Models

Download this eBook from The Scientist and Synthego to find out about CRISPR's translational potential in generating transgenic animals and where it can take you in the future!

Nov 6, 2017
The Scientist Creative Services Team

CRISPR genome-editing technology is only five years old, but it has already made remarkable strides in biomedical, microbial, and agricultural research. CRISPR affords scientists the ability to edit multiple genes at once in any extant organism, which is especially relevant for generating in vivo model systems for pathologies like cancer. With CRISPR, researchers can now easily tailor the genome of an organism to suit their needs, with minimal prior animal model development experience required.

Download this eBook from The Scientist to learn about:
 • How CRISPR works and its translational potential
 • The steps to generating a new transgenic animal model using CRISPR
 • CRISPR's place in the transgenic toolkit
 • Where CRISPR has already gone, and where it can go in the future

This free eBook was made possible by an educational grant from Synthego.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.